Best Biopharma Outsourcing Companies in Scotland, United Kingdom
The 39 best Biopharma Outsourcing companies in Scotland, United Kingdom in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: ClinTec.
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Scotland
| # | Company | Last round | Disclosed funding | Employees | Founder | Stage | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | BioOutsource CRO specialising in biological analysis of biologics and biosimilars | — | — | 85 | Hugo De Wit CEO & MD | Unfunded | — | — |
| 2 | Blue Vector Provider of business and technical consultancy to life science industries | — | — | — | Cheryl Lockett Managing Director & Co-Owner | Unfunded | — | — |
| 3 | BluTest Microbiology contract research organization | — | — | 16 16 → 13 (-19%) | Chris Woodall Founder & CEO | Unfunded | — | — |
| 4 | Charnwood Campus CRO offering clinical research sites which conduct clinical trials | — | — | 3 | — | Unfunded | — | 1 award |
| 5 | Compliance Solutions Consultancy firm providing regulatory advice and compliance services to life science companies, specializing… | — | — | — | — | Acquired | — | 1 partnership |
| 6 | Core Oncology UK-based oncology-specific clinical trial consulting company | — | — | — | — | Unfunded | — | — |
| 7 | CPS Research Company offering site management and patient recruitment services | — | — | — | Gordon Crawford Co-Founder | Unfunded | — | — |
| 8 | Cypex Company offering in vitro drug metabolism services using their patented technology for producing recombinant… | — | — | 5 | — | Acquired | — | — |
Top 12 Biopharma Outsourcing companies in Scotland
#1
Seed · Glasgow, Scotland · founded 2022$5Mraised▾
Developer of biologic drugs for chronic inflammatory conditions. It allows patients to form natural antibodies against harmful targets. It focuses on targeting inflammatory conditions such as senile pruritus, atopic dermatitis, eczema, and asthma.
- Apr 2024Seed$5M
#2
Series A · Glasgow, Scotland · founded 2010 · 22 employees$6.9Mraised▾
Provider of formulation development services specializing in gamma scintigraphy
- Aug 2023Series A$2.5M
- Dec 2020Series A$1.6M
- Jul 2020Series A—
- Mar 2018Seed$2.8M
#3
Funding Raised · Ayr, Scotland · founded 2006 · 11 employees$6.1Mraised▾
Developer of a cell culture technology designed to be used in drug discovery, biomedical research and natural product testing. The company's technology provides its expertise in a range of services ranging from off-the-shelf cell-based assays to specialist cell culture systems, that are customized to meet customers' requirements, enabling customers to evaluate bio-activity or bio-safety in a wide-range of test materials, from pharmaceuticals, traditional medicines and natural products to medical devices and nano-structured materials.
- Jan 2018Grant (prize money)$738.4K
- Jan 2017Grant (prize money)$337.3K
- Oct 2016Grant (prize money)$875.9K
- Jan 2016Grant (prize money)$402.9K
#4
Acquired · Glasgow, Scotland · founded 1997$12.5Mraised▾
ClinTec International, a clinical research organization, provides clinical research personnel and support services to pharmaceutical, biotechnology, and medical device industries. It offers clinical research services, such as project management, monitoring, data management, biostatistics, quality assurance, drug development consultancy, and medical writing; and clinical insourcing and patient recruitment/retention services. The company also provides consulting services, such as strategic planning, regulatory, feasibility studies, and clinical research and clinical trial regulations training; and clinical resourcing services. It offers its services in various therapeutic categories, including oncology, neurology, cardiovascular, psychiatry, infectious disease, rheumatology, immunology, respiratory, and gastroenterology.
- Aug 2010PE$12.5M
#5
Seed · Motherwell, Scotland · founded 2013 · 41 employees$3.7Mraised▾
BioAscent is a provider of compound management solutions for drug discovery. Their service portfolio includes Compound Management, Compound Cloud, Compound Collection Sharing, and Compound Collection Disaster Recovery. The company is currently operating a former automated compound Management and Logistics facility of Merck. They offer a confidential partner-matching service which facilitates compound collection sharing (based on owner's terms) with pharma, biotech and academic institutes.
- Jun 2018Seed$3.7M
- Mar 2014Seed—
- Nov 2013Seed—
#6
Funding Raised · Stirling, Scotland · founded 2011 · 119 employees$1.2Mraised▾
Symbiosis Pharmaceutical Services is a contract manufacturer of sterile injectables - both biologics and small molecules for clinical trials and commercial supplies (for niche markets and orphan indications).Through their MHRA-licensed facility, they can fill bulk volumes under 100 litres for products that require aseptic liquid filling and lyophilisation. These include products such as biologics (including mAb’s, proteins, peptides and RNA), cytotoxic, cytostatic and high potent APIs including ADCs and small molecules. They claim that they can offer rapid access to manufacturing slots and quick release of drug product to ensure tight timelines are successfully met during clinical trials. Their commercial scale offering largely caters to companies involved that require relatively low volume or infrequent sterile filling. Their development services include formulation development, lyophilization cycle development, non-GMP process development and leachables. They also offer drug product testing, Qualified Person Release and Clinical Labelling and Packaging Services.
- Jul 2020Conventional Debt$1.2M
- Grant (prize money)—
#7
Series A · Holytown, Scotland · founded 2012 · 6 employees$3.5Mraised▾
Clyde Biosciences is a boutique Contract Research Organisation for cardiac safety testing. Clyde’s CellOPTIQ™ platform delivers high-resolution functional output from a range of cardiac cell types including iPS-derived heart cells. High bandwidth membrane voltage signals from CellOPTIQ™ provides insights into electrophysiological effects of drugs. Rapid data capture and analysis is made possible by their bespoke software which allows accelerated assay throughput in a 96 well format. Their services include Calcium, Voltage, Contractility, In Silico Modelling, CiPA Studies, Bespoke R&D.
- Sep 2015Grant (prize money)$300.9K
- Mar 2015Series A$3.5M
#8
Deadpooled · Selkirk, Scotland · founded 1996$3.9Mraised▾
Ecto Pharma is a virtual pharmaceutical and biotechnology company focused on commercializing patented technologies in human and veterinary science. Its approach is to build strategic alliances with other companies to carry out R&D work into effective new products before out-licensing manufacturing and marketing rights to third parties. It is also working on gene therapy Ryboquin for cancer.
- Dec 2010Grant (prize money)$114.6K
- Apr 2007Series A$3.9M
#9
Acquired · Edinburgh, Scotland · founded 2011 · 489 employees$940.3Kraised▾
Aquila BioMedical is a preclinical contract research organization with particular focus on Immunology, Regeneration, Neuroscience and Histology with therapeutic relevance for Multiple Sclerosis (MS), Autoimmune Disease, Inflammation, Pain and beyond, covering a wide range of in-vitro and in-vivo proof-of-concept studies.
- May 2020Grant (prize money)$940.3K
- Jan 2016Grant (prize money)—
#10
Seed · Edinburgh, Scotland · founded 2016 · 23 employees$1.7Mraised▾
Censobio is a stem cell technology based CRO offering contract research services for drug discovery, toxicity testing and cell banking. The company was formed by the merger of Roslin Cellab and Roslin Cell Sciences, both of which were based out of UK in 2016. Through their technology they first generate iPSCs and then create other differentiated cells such as Neuronal cells, Cardiomyocytes, and Macrophages. These physiologically relevant cells can then be used for a variety of assays that can help in compound screening, target validation, toxicity testing and patient stratification. Their iPSC-related services include Custom iPSC generation, Cell line expansion and banking, Cell line QC and validation. Censobio also offers cell culture services and in vitro assays for drug discovery and toxicity testing purposes.
- Oct 2018Seed$1.7M
#11
Funding Raised · Glasgow, Scotland · founded 2004 · 11 employees$982.3Kraised▾
Provider of bioformulation and drug delivery technologies for biologics and vaccines. It focuses on formulation and delivery of biologics through injection, inhalation, oral, and nasal routes. It formulates APIs including mAbs, mAb fragments, cytokines, hormones, plasmids, and peptides. The company also offers solid-state circular dichroism services for measuring bio-stability and vaccine potency. It has proprietary technology available for licensing that addresses bioformulation and delivery challenges, such as high concentration protein solutions, sustained release of biologics, thermally stable vaccines, and dry biologic powders for inhalation.
- Apr 2015Grant (prize money)$465.7K
- Jan 2015Grant (prize money)$516.6K
#12
Series A · Glasgow, Scotland · founded 2010 · 5 employees$1Mraised▾
Sistemic is a development stage biomedical company that focuses on harnessing the information contained in the miRNA and other non-coding RNA content of cells for applications in the development of cell therapies and drug repositioning. The company offers a proprietary platform technology called SistemRNA that applies a compound centric approach to identifying drug effects by measuring associative changes in miRNA profiles and analysing the data in context. This offers the possibility of using this platform within the drug discovery pipeline as a decision support aid. Other offerings include SistemQC for quality control in various stages of cell therapies, SistemTox (Applicable to cell lines such as HepG2, as well as stem cells derived from hepatocytes and cardiomyocytes) for identifying potential toxicity of compounds. SistemKB is a highly curated database of biological functions and interactions of miRNA.
- Jan 2015Series A$1M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
What Scotland researches in biotechnology
- Scotland\'s Rural College14
- University of the West of Scotland4
- Biomathematics and Statistics Scotland3
- Cancer Research UK Scotland Institute1
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.